Dendritic cells transfected with hepatocellular carcinoma (HCC) total RNA induce specific immune responses against HCC in vitro and in vivo

Clinical and Translational Oncology

Volumn 16, Issue 8, 2014, Pages 753-760

  Xie, B H ^a,b   Yang, J Y ^a   Li, H P ^a   Zhang, B ^a   Chen, W ^a   Zhou, B ^a   Peng, B G ^a   Liang, L J ^a   He, Q ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GANNAN MEDICAL UNIVERSITY   (China)

Author keywords

Cytotoxic T lymphocytes; Dendritic cells; Hepatocellular carcinoma; Peripheral blood mononuclear cells; Recurrence

Indexed keywords

CD14 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; DENDRITIC CELL VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPG 2 RNA DENDRITIC CELL VACCINE; HLA DR ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 4; RNA VACCINE; TUMOR VACCINE; UNCLASSIFIED DRUG; CANCER VACCINE; RNA; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CANCER GROWTH; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CELL AGGREGATION; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATOCELLULAR CARCINOMA CELL LINE; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RNA IMMUNIZATION; SCID MOUSE; T LYMPHOCYTE; ANIMAL; DRUG SCREENING; FLOW CYTOMETRY; IMMUNOLOGY; LIVER TUMOR; TRANSPLANTATION;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CARCINOMA, HEPATOCELLULAR; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IN VITRO TECHNIQUES; LIVER NEOPLASMS; MICE; RNA, NEOPLASM; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84904509371     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-013-1145-7     Document Type: Article

References (27)

1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767-811. (Pubitemid 30365397)
2. Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G, et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol. 1996;26:659-68. (Pubitemid 26091397)
3. Nouri-Shirazi M, Banchereau J, Fay J, Palucka K. Dendritic cell based tumor vaccines. Immunol Lett. 2000;74:5-10.
4. Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, et al. Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res. 2000;6:1755-66. (Pubitemid 30305068)
5. Halliday GM, Le S. Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin. Int Immunol. 2001;13:1147-54. (Pubitemid 32899157)
6. Ohm JE, Carbone DP. VEGF as a mediator of tumor-associated immunodeficiency. Immunol Res. 2001;23:263-72. (Pubitemid 32575367)
7. Cao H, Verge V, Baron C, Martinache C, Leon A, Scholl S, et al. In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy. J Hematother Stem Cell Res. 2000;9:183-94. (Pubitemid 30305123)
8. Garderet L, Cao H, Salamero J, Vergé V, Tisserand E, Scholl S, et al. In vitro production of dendritic cells from human blood monocytes for therapeutic use. J Hematother Stem Cell Res. 2001;10:553-67. (Pubitemid 32756194)
9. Zheng Z, Takahashi M, Narita M, Toba K, Liu A, Furukawa T, et al. Generation of dendritic cells from adherent cells of cord blood by culture with granulocytemacrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha. J Hematother Stem Cell Res. 2000;9:453-64.
10. Ramadan G, Schmidt RE, Schubert J. In vitro generation of human CD86+ dendritic cells from CD34 + haematopoietic progenitors by PMA and in serumfree medium. Clin Exp Immunol. 2001;125:237-44. (Pubitemid 32758434)
11. Hagihara M, Li C, Gansuvd B, Munkhbat B, Inoue H, Shimakura Y, et al. Extensive and long-term ex vivo production of dendritic cells from CD34 positive umbilical cord blood or bone marrow cells by novel culture system using mouse stroma. J Immunol Methods. 2001;253:45-55. (Pubitemid 32522514)
12. Mitchell DA, Nair SK. RNA-transfected dendritic cells in cancer immunotherapy. J Clin Invest. 2000;106:1065-9.
13. Saenz-Badillos J, Amin SP, Granstein RD. RNA as a tumor vaccine: a review of the literature. Exp Dermatol. 2001;10:143-54. (Pubitemid 32492476)
14. Kariko K, Kuo A, Barnathan ES, Langer DJ. Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA. Biochim Biophys Acta. 1998;1369:320-34. (Pubitemid 28132870)
15. Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med. 1996;184:465-72. (Pubitemid 26324100)
16. Zhang W, He L, Yuan Z, Xie Z, Wang J, Hamada H, et al. Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin. Hum Gene Ther. 1999;10:1151-61. (Pubitemid 29233384)
17. Koido S, Kashiwaba M, Chen D, Gendler S, Kufe D, Gong J. Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. J Immunol. 2000;165:5713-9.
18. Nair SK, Boczkowski D, Morse M, Cumming RI, Lyerly HK, Gilboa E. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat Biotechnol. 1998;16:364-9. (Pubitemid 28164657)
19. Nair SK, Hull S, Coleman D, Gilboa E, Lyerly HK, Morse MA. Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA. Int J Cancer. 1999;82:121-4. (Pubitemid 29266116)
20. Nair SK, Morse M, Boczkowski D, Cumming RI, Vasovic L, Gilboa E, et al. Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Ann Surg. 2002;235:540-9. (Pubitemid 34258354)
21. Nair SK, Heiser A, Boczkowski D, Majumdar A, Naoe M, Lebkowski JS, et al. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med. 2000;6:1011-7.
22. Boczkowski D, Nair SK, Nam JH, Lyerly HK, Gilboa E. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res. 2000; 60:1028-34. (Pubitemid 30129541)
23. Heiser A, Maurice MA, Yancey DR, Coleman DM, Dahm P, Vieweg J. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors. Cancer Res. 2001;61:3388-93. (Pubitemid 32695030)
24. Heiser A, Maurice MA, Yancey DR, Wu NZ, Dahm P, Pruitt SK, et al. Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA. J Immunol. 2001;166:2953-60. (Pubitemid 33117290)
25. Heiser A, Dahm P, Yancey DR, Maurice MA, Boczkowski D, Nair SK, et al. Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J Immunol. 2000;164: 5508-14. (Pubitemid 30305236)
26. Su Z, Dannull J, Heiser A, Yancey D, Pruitt S, Madden J, et al. Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. Cancer Res. 2003;63:2127-33. (Pubitemid 36538616)
27. Yewdall AW, Drutman SB, Jinwala F, Bahjat KS, Bhardwaj N. CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells. PLoS One. 2010. doi:10.1371/journal.pone.0011144.